AJP - Renal Physiology, Vol 263, Issue 1 97-102, Copyright © 1992 by American Physiological Society

ARTICLES

Regulation of mesangial cell cyclooxygenase synthesis by cytokines and glucocorticoids

D. W. Coyne, M. Nickols, W. Bertrand and A. R. Morrison
Department of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110.

The cytokines, interleukin-1 (IL-1) and tumor necrosis factor (TNF), potently induce prostaglandin formation in glomerular mesangial cells. Mechanisms by which these cytokines stimulate prostaglandin formation vary among cell types. We investigated whether alterations in phospholipase A2 (PLA2) or cyclooxygenase (COX) mass and activity contribute to the changes in mesangial cell prostaglandin production. These cytokines induced COX activity and mass in a time-dependent manner, which paralleled prostaglandin production. IL-1 increased COX mass approximately threefold by 24 h. TNF had a much smaller effect, although it appeared to be additive with IL-1. IL-1-induced COX mass was maintained at an increased level for at least 48 h. The glucocorticoid dexamethasone (DEX) virtually abolished prostaglandin production and blocked cytokine induction of COX activity and mass. DEX did not reduce COX activity or mass below the basal, serum-fed levels, however. By utilizing stable isotope methods, we could demonstrate that IL-1 increased free arachidonate levels, implying new PLA2 synthesis over a time course that was maximal at 6 h and was cycloheximide and actinomycin D sensitive. These data demonstrate that the cytokines IL-1 and TNF enhance synthesis of COX and PLA2, contributing to increased prostaglandin production. Cytokine-stimulated prostaglandin production ceases when cells are also treated with DEX, although control levels of COX activity and mass remain. This occurs because DEX inhibits the IL-1-induced enhanced arachidonate release.

This article has been cited by other articles:

				L M Jackson, K C Wu, Y R Mahida, D Jenkins, and C J Hawkey Cyclooxygenase (COX) 1 and 2 in normal, inflamed, and ulcerated human gastric mucosa Gut, December 1, 2000; 47(6): 762 - 770. [Abstract] [Full Text] [PDF]

				P. E. Moore, J. D. Laporte, S. Gonzalez, W. Moller, J. Heyder, R. A. Panettieri Jr., and S. A. Shore Glucocorticoids ablate IL-1beta -induced beta -adrenergic hyporesponsiveness in human airway smooth muscle cells Am J Physiol Lung Cell Mol Physiol, November 1, 1999; 277(5): L932 - L942. [Abstract] [Full Text] [PDF]

				N. R. Ferreri, S.-J. An, and J. C. McGiff Cyclooxygenase-2 expression and function in the medullary thick ascending limb Am J Physiol Renal Physiol, September 1, 1999; 277(3): F360 - F368. [Abstract] [Full Text] [PDF]

				M. Barrios-Rodiles and K. Chadee Novel Regulation of Cyclooxygenase-2 Expression and Prostaglandin E2 Production by IFN-{gamma} in Human Macrophages J. Immunol., September 1, 1998; 161(5): 2441 - 2448. [Abstract] [Full Text] [PDF]

				Y. Fukumoto, H. Shimokawa, T. Kozai, T. Kadokami, K. Kuwata, Y. Yonemitsu, T. Kuga, K. Egashira, K. Sueishi, and A. Takeshita Vasculoprotective Role of Inducible Nitric Oxide Synthase at Inflammatory Coronary Lesions Induced by Chronic Treatment With Interleukin-1ß in Pigs in Vivo Circulation, November 4, 1997; 96(9): 3104 - 3111. [Abstract] [Full Text]

				M. Hernandez, L. Fuentes, F. J. Fernandez Aviles, M. S. Crespo, and M. L. Nieto Secretory Phospholipase A2 Elicits Proinflammatory Changes and Upregulates the Surface Expression of Fas Ligand in Monocytic Cells: Potential Relevance for Atherogenesis Circ. Res., January 11, 2002; 90(1): 38 - 45. [Abstract] [Full Text] [PDF]